Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for ...

A WOMAN has revealed losing eight stone gave her the confidence to wear a wedding dress – and finally say ‘yes’ to her ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: You can drink alcohol on tirzepatide, but it may slow your weight loss and ...

The FDA has granted Priority Review to the sNDA for olezarsen in the treatment of severe hypertriglyceridemia.

GLP-1s were first approved in 2005 for the treatment of Type 2 diabetes. Since then, more versions of the medication have hit the market, becoming more accessible to patients and used for a wider ...

Unexplainable weight reduction together with decreased appetite and anemia and alterations in bowel movements should always be treated as serious medical issues when experienced with stomach ...

And why taking it safely matters more than the hype.

Dr Manoj Bharucha says GLP-1 medications are not 'beauty treatments', but powerful metabolic tools that need medical supervision. So, who's eligible? Find out.

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Strategic Initiatives and Refined Business Model Produced Financial and Operating EfficienciesEstablished Long-Term License and Supply Agreement ...